Patents by Inventor Jaswinder Bains

Jaswinder Bains has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sterol glucoside toxins
    Patent number: 8497123
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitostrol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: July 30, 2013
    Assignee: Neurodyn, Inc.
    Inventors: Christohper A. Shaw, Raymond J. Andersen, David E. Williams, Jaswinder Bains
  • STEROL GLUCOSIDE TOXINS
    Publication number: 20120244632
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitostrol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Application
    Filed: March 30, 2012
    Publication date: September 27, 2012
    Applicant: NEURODYN, INC.
    Inventors: Christopher Ariel SHAW, Raymond J. ANDERSEN, David E. WILLIAMS, Jaswinder BAINS
  • Sterol glucoside toxins
    Patent number: 8148336
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitosterol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: April 3, 2012
    Assignee: Neurodyn, Inc.
    Inventors: Christopher Ariel Shaw, Raymond J Andersen, David E Williams, Jaswinder Bains
  • Sterol glucoside toxins
    Publication number: 20060252705
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitostrol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Application
    Filed: June 29, 2006
    Publication date: November 9, 2006
    Inventors: Christopher Shaw, Raymond Andersen, David Williams, Jaswinder Bains
  • Sterol glucoside toxins
    Publication number: 20040048810
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitostrol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Application
    Filed: September 3, 2003
    Publication date: March 11, 2004
    Inventors: Christopher Ariel Shaw, Raymond J Andersen, David E Williams, Jaswinder Bains